Sivaraj, D http://orcid.org/0000-0001-7453-0045
Bacon, W
Long, G D
Rizzieri, D A
Horwitz, M E
Sullivan, K M
Kang, Y
Li, Z
Chao, N J
Gasparetto, C
Article History
Received: 25 February 2017
Revised: 8 July 2017
Accepted: 16 August 2017
First Online: 30 October 2017
Competing interests
: CG serves as a speaker/consultant/advisor to Celgene, Takeda Oncology and Onyx and has received research funding from Celgene. DAR serves as a speaker to Celgene. The remaining authors declare no conflict of interest.